Claim being checked · Version 1 · Reviewed August 30, 2026

“Kisspeptin-10 is FDA-approved.”

Written and source-checked by Anthony Treviso, founder of The Peptide Field.

No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.

Misleading. This statement leaves out a limit that changes its meaning.

Answer scope

This verdict checks the exact claim in the heading. It is not a universal grade for Kisspeptin-10.

01 · Answer

Misleading

No FDA-approved product was identified. An FDA identity record does not mean approval. FDA also lists Kisspeptin-10 among substances that may present significant safety risks in compounding.

What kind of evidence this is: Regulatory or product record. This answer uses an official regulator record or a specific product label.
What this answer covers: United States status as reviewed August 30, 2026. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
Question type: Approval and status. Whether a specific product has an approval or another official status.

02 · Sources

Read the sources behind this answer

01FDA review of Kisspeptin-10 for pharmacy compoundingU.S. Food and Drug Administration · FDA review · 2024
Supports the corrective verdict 02FDA list of substances that may present compounding safety risksU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict 03FDA substance identity record for Kisspeptin-10U.S. Food and Drug Administration · Reference · 2026
Supports the corrective verdict

Editorial review: Internal editorial review recorded
Source review: Anthony Treviso · Founder and responsible editor
Medical review status: Not independently medically reviewed. Editorial source review does not replace medical review.